Lexicon Pharma (LXRX) Tops Q2 EPS by 3c

July 30, 2021 7:08 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $234 thousand, versus $9.16 million reported last year.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities